Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 216 participants.

Also called NCT02059785

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 216 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02059785
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT02059785. Randomized; triple masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke
Intervention (Drug)
Pinocembrin for Injection
Lead sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02059785
Content hash
d8ba62947830081551c34832fe206a50257fbf72fd4c22e680dcecbf27c479b8